n

(redirected from neuraminidase)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to neuraminidase: sialic acid, Neuraminidase inhibitor

N

Fifth letter in a Nasdaq stock symbol specifying that the issue is the company's third class of preferred shares.

n

Used in stock transaction tables in newspapers to indicate a new stock that has been listed within the past 52 weeks. The high and low prices are for a period of less than a year: WeinR n.
Mentioned in ?
References in periodicals archive ?
The presence of 2 mutations in neuraminidase from the specimen of patient 3, which contained the highest viral load, might suggest a correlation with the efficiency of infection and replication in the conjunctiva.
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Influenza virus A interacts with their hosts mostly through two critical glycoproteins, hemagglutinin (HA-16) and neuraminidase (NA-9) subtypes.
In fact, published studies by others have recently reported IAP deficiencies and high neuraminidase levels in IBD patients."
A great Australian example of this kind of work is the study of a molecule from the virus that causes influenza, called neuraminidase. In the 1980s and 90s, researchers from the CSIRO, led by Peter Colman, used a synchrotron to perform X-ray crystallographic studies of neuraminidase to determine its molecular structure [Colman, P.M.
It uses an enzyme, neuraminidase, to break apart the cell walls so that it can enter.
It meant that GSH levels in saliva and blood were equally reliable diagnostic tests.The neuraminidase levels obtained were 233.1536.13 (mg/100ml) and 279.1873.75 (mg/100ml) in control and patient groups respectively from blood samples which were significant (pless than 0.05).
The [[beta].sub.2]-transferrin in CSF is desialylated because of the presence of neuraminidase in the central nervous system.
If started promptly, antiviral medications may reduce complications of acute influenza, but increasing resistance to amantadine and perhaps neuraminidase inhibitors underscores the need for novel prevention and treatment strategies.
[3-6] In September 2009 Jefferson asked Roche for the unpublished data set that Roche used in an analysis published in 2003, for use the following month to update the Cochrane Collaboration's review on neuraminidase inhibitors in healthy adults.
Hemagglutinin and neuraminidase are two key proteins displayed on the surface of the virus particle; they are the H and N used in virus strain names like H1N1.